Hypnotics and sedatives

作者: Marcia Divoll Allen , David J. Greenblatt

DOI: 10.1016/S0378-6080(80)80008-0

关键词:

摘要: Publisher Summary This chapter discusses several adverse effects of hypnotics and sedatives. The reduction in the use barbiturates over past years has sharply reduced number deaths, particularly suicides, from barbiturate overdose. However, only a very small decline can be detected overall drug suicide rate. extent to which normal dosage benzodiazepines actually produces addiction is unknown, but should suspected when patient repeatedly tries wean himself benzodiazepine restarts treatment because headache, dysphoria, or symptoms unrelated initial anxiety syndrome. Triazolam, short-acting hypnotic, was recently temporarily withdrawn market Netherlands Luxemburg reported side such as severe malaise, depersonalization, depression, cervical pains, impaired motor function, blurred vision, dysfunctional speaking writing, suicidal tendencies. phenomena receptor-site tolerance adaptation greatly complicate interpretation blood levels pharmacokinetics relation clinical effect. A given level may have one effect at time different later after period exposure elapsed. It conceivable that concentrations pharmacokinetic properties bear type relationship non-specific sedative effects, an entirely anti-anxiety effects.

参考文章(185)
Jacobs Wh, Franks E, Cholestatic jaundice possibly due to benzodiazepine-type drugs. Missouri medicine. ,vol. 72, pp. 605- ,(1975)
Adams Hr, Gross Dr, Kitzman Jv, Cardiovascular effects of intravenous administration of propylene glycol and of oxytetracycline in propylene glycol in calves. American Journal of Veterinary Research. ,vol. 40, pp. 783- 791 ,(1979)
J. G. W. Burdon, J. F. Cade, "Barbiturate burns" caused by glutethimide. The Medical Journal of Australia. ,vol. 1, pp. 101- 102 ,(1979) , 10.5694/J.1326-5377.1979.TB112032.X
C G H Newman, Clinical observations on the thalidomide syndrome. Journal of the Royal Society of Medicine. ,vol. 70, pp. 225- 227 ,(1977) , 10.1177/003591577707000403
Connell Ph, What is barbiturate dependence and who is at risk Journal of Medical Ethics. ,vol. 2, pp. 58- 62 ,(1976)
Graham D. Burrows, Peter Dumovic, Judith A. Smith, Trevor Norman, Kay Maguire, A controlled comparative trial of clorazepate (Tranxene) and diazepam (Valium) for anxiety. The Medical Journal of Australia. ,vol. 2, pp. 525- 528 ,(1977) , 10.5694/J.1326-5377.1977.TB114618.X
David J. Greenblatt, Marcia D. Allen, Richard I. Shader, Toxicity of high-dose flurazepam in the elderly Clinical Pharmacology & Therapeutics. ,vol. 21, pp. 355- 361 ,(1977) , 10.1002/CPT1977213355
J H Weir, Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation The Journal of Clinical Psychiatry. ,vol. 39, pp. 841- 847 ,(1978)